Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Tempus AI, Inc. (NASDAQ:TEM) has received a consensus rating of "Moderate Buy" from analysts, with six analysts rating it as a hold and seven as a buy.
• The average 1-year price target set by analysts for Tempus AI stock is $71.83, with significant adjustments from firms such as Guggenheim, which raised their target from $80.00 to $95.00.
• Tempus AI reported a revenue of $314.64 million for the last quarter, exceeding analyst estimates, and demonstrated an 89.5% year-over-year revenue growth despite a negative EPS of ($0.22).

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the thirteen analysts that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $71.8333.

TEM has been the subject of several analyst reports. Morgan Stanley raised their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. Guggenheim raised their target price on shares of Tempus AI from $80.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 26th. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. BTIG Research lifted their price objective on shares of Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a report on Wednesday, August 20th. Finally, Bank of America lifted their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th.

Tempus AI Price Performance

Tempus AI stock opened at $87.99 on Thursday. The firm has a 50-day moving average price of $73.92 and a 200-day moving average price of $62.59. The firm has a market capitalization of $15.29 billion, a PE ratio of -73.94 and a beta of 4.89. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI has a 12-month low of $31.36 and a 12-month high of $97.79.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business's revenue was up 89.5% on a year-over-year basis. During the same quarter last year, the business earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Tempus AI will post -6.15 EPS for the current year.

Insider Activity at Tempus AI

In related news, EVP Erik Phelps sold 3,664 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president owned 94,115 shares in the company, valued at $7,025,684.75. This trade represents a 3.75% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the sale, the chief executive officer owned 9,141,032 shares of the company's stock, valued at $699,837,409.92. The trade was a 3.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 933,662 shares of company stock worth $67,909,393 over the last ninety days. 26.27% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Tempus AI

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TEM. Concord Wealth Partners increased its position in Tempus AI by 308.0% during the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after purchasing an additional 308 shares during the period. Allworth Financial LP increased its position in Tempus AI by 5,000.0% during the 2nd quarter. Allworth Financial LP now owns 459 shares of the company's stock valued at $29,000 after purchasing an additional 450 shares during the period. Cherry Tree Wealth Management LLC purchased a new position in Tempus AI during the 1st quarter valued at about $31,000. SouthState Corp increased its position in Tempus AI by 3,761.5% during the 2nd quarter. SouthState Corp now owns 502 shares of the company's stock valued at $32,000 after purchasing an additional 489 shares during the period. Finally, University of Texas Texas AM Investment Management Co. purchased a new position in Tempus AI during the 1st quarter valued at about $33,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.